Total Payments
$297,304
2024 Payments
$87,821
Companies
77
Transactions
2,024
Medicare Patients
10,774
Medicare Billing
$887,468
Payment Breakdown by Category
Other$181,922 (61.2%)
Consulting$55,545 (18.7%)
Food & Beverage$35,870 (12.1%)
Travel$20,351 (6.8%)
Research$3,305 (1.1%)
Education$193.33 (0.1%)
Gifts$118.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $141,892 | 84 | 47.7% |
| Consulting Fee | $55,545 | 26 | 18.7% |
| Food and Beverage | $35,870 | 1,811 | 12.1% |
| Honoraria | $35,350 | 13 | 11.9% |
| Travel and Lodging | $20,351 | 58 | 6.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $3,680 | 2 | 1.2% |
| Unspecified | $3,305 | 12 | 1.1% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $1,000 | 1 | 0.3% |
| Education | $193.33 | 15 | 0.1% |
| Gift | $118.80 | 2 | 0.0% |
Payments by Type
General
$294,000
2,012 transactions
Research
$3,305
12 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Corcept Therapeutics | $217,384 | 286 | $0 (2024) |
| Merck Sharp & Dohme LLC | $24,822 | 78 | $0 (2023) |
| ABBVIE INC. | $18,176 | 72 | $0 (2024) |
| Lilly USA, LLC | $6,897 | 192 | $0 (2024) |
| Aegerion Pharmaceuticals, Inc. | $4,482 | 10 | $0 (2018) |
| Novo Nordisk Inc | $3,005 | 215 | $0 (2024) |
| Insulet Corporation | $2,659 | 85 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,660 | 89 | $0 (2024) |
| Amgen Inc. | $1,490 | 90 | $0 (2024) |
| Abbott Laboratories | $1,352 | 85 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $87,821 | 259 | Corcept Therapeutics ($84,204) |
| 2023 | $31,134 | 258 | Corcept Therapeutics ($27,249) |
| 2022 | $18,130 | 254 | Corcept Therapeutics ($13,510) |
| 2021 | $33,471 | 229 | Corcept Therapeutics ($24,407) |
| 2020 | $14,898 | 204 | Corcept Therapeutics ($5,699) |
| 2019 | $49,836 | 277 | Corcept Therapeutics ($28,103) |
| 2018 | $43,105 | 294 | Corcept Therapeutics ($26,866) |
| 2017 | $18,910 | 249 | Corcept Therapeutics ($7,346) |
All Payment Transactions
2,024 individual payment records from CMS Open Payments — Page 1 of 81
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes Care | ||||||
| 12/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Diabetes Care | ||||||
| 12/23/2024 | Corcept Therapeutics | Korlym (Drug) | Consulting Fee | Cash or cash equivalent | $3,150.00 | General |
| Category: Endocrinology | ||||||
| 12/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $189.66 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Obesity | ||||||
| 12/03/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $43.20 | General |
| Category: Automated insulin delivery system | ||||||
| 12/02/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: LIVER DISEASE | ||||||
| 11/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Endocrinology | ||||||
| 11/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,900.00 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $105.31 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $64.80 | General |
| Category: Automated insulin delivery system | ||||||
| 11/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $352.30 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CATALYST | Corcept Therapeutics | $2,405 | 10 |
| MEASuRE | Aegerion Pharmaceuticals, Inc. | $900.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,460 | 7,872 | $714,856 | $218,581 |
| 2022 | 28 | 2,727 | 7,649 | $749,641 | $225,435 |
| 2021 | 28 | 2,694 | 8,333 | $758,274 | $238,629 |
| 2020 | 32 | 2,893 | 7,348 | $724,619 | $204,824 |
Total Patients
10,774
Total Services
31,202
Medicare Billing
$887,468
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 36 | 3,660 | $164,700 | $66,591 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 348 | 726 | $196,020 | $64,765 | 33.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 104 | 195 | $34,125 | $11,937 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 59 | 84 | $30,240 | $10,709 | 35.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 128 | 350 | $38,500 | $9,071 | 23.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 99 | 226 | $21,470 | $8,754 | 40.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 274 | 629 | $31,450 | $5,968 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 88 | $17,600 | $5,676 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $13,875 | $4,534 | 32.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 46 | $14,030 | $4,369 | 31.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 155 | 237 | $18,486 | $3,901 | 21.1% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 47 | 47 | $14,335 | $3,835 | 26.7% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 118 | 180 | $28,800 | $2,988 | 10.4% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 20 | 22 | $11,000 | $2,262 | 20.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 156 | 237 | $11,850 | $2,095 | 17.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 149 | 202 | $10,100 | $2,091 | 20.7% |
| 82948 | Blood glucose (sugar) measurement using reagent strip | Office | 2023 | 202 | 393 | $7,860 | $1,927 | 24.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 99 | 112 | $8,960 | $1,469 | 16.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 42 | 44 | $4,400 | $1,276 | 29.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 26 | $3,900 | $1,157 | 29.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 95 | $11,875 | $1,037 | 8.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 19 | 27 | $4,455 | $682.83 | 15.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 42 | 57 | $2,280 | $433.77 | 19.0% |
| 82533 | Cortisol (hormone) measurement, total | Office | 2023 | 18 | 25 | $6,250 | $399.25 | 6.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 57 | 60 | $6,300 | $339.60 | 5.4% |
About Dr. Jonathan Ownby, M.D
Dr. Jonathan Ownby, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1780887877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Ownby, M.D has received a total of $297,304 in payments from pharmaceutical and medical device companies, with $87,821 received in 2024. These payments were reported across 2,024 transactions from 77 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($141,892).
As a Medicare-enrolled provider, Ownby has provided services to 10,774 Medicare beneficiaries, totaling 31,202 services with total Medicare billing of $887,468. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Atlanta, GA
- Active Since 06/07/2007
- Last Updated 04/04/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1780887877
Products in Payments
- Korlym (Drug) $217,384
- STEGLATRO (Drug) $17,687
- Synthroid (Drug) $8,394
- SYNTHROID (Drug) $6,863
- JANUVIA (Drug) $4,639
- MYALEPT (Drug) $4,527
- HUMULIN (Drug) $3,861
- Omnipod (Device) $2,659
- JANUMET (Drug) $2,385
- Ozempic (Drug) $1,121
- TRULICITY (Drug) $1,039
- JARDIANCE (Drug) $1,013
- AFREZZA (Drug) $985.67
- FARXIGA (Drug) $921.81
- t-slim insulin pump (Device) $773.61
- UNITHROID (Drug) $627.42
- Repatha (Biological) $600.49
- FREESTYLE LIBRE 3 (Device) $594.29
- V-GO (Device) $590.24
- GVOKE HYPOPEN (Drug) $567.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Atlanta
Bruce Bode, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $2.9M
Endocrinology, Diabetes & Metabolism $2.9M
David Robertson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $2.0M
Endocrinology, Diabetes & Metabolism $2.0M
Guillermo Umpierrez, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $103,343
Endocrinology, Diabetes & Metabolism $103,343
Francisco Pasquel, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $88,785
Endocrinology, Diabetes & Metabolism $88,785
Priyathama Vellanki, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $61,485
Endocrinology, Diabetes & Metabolism $61,485
Dr. Scott Isaacs, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $57,100
Endocrinology, Diabetes & Metabolism $57,100